Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 29562145

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Apr 5
First author
Motzer RJ

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Apr 5;378(14):1344-1345. doi: 10.1056/NEJMe1801682.
    note
    Source null
    related pmid
    29562143
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2018 May;15(5):261. doi: 10.1038/nrurol.2018.47.
    note
    Source null
    related pmid
    29632348
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2018 Jun;15(6):343. doi: 10.1038/s41571-018-0020-4.
    note
    Source null
    related pmid
    29666439
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Jul 05;379(1):91-2. doi: 10.1056/NEJMc1805988.
    note
    Source null
    related pmid
    29975027
    relationship
    Comment in
  5. citation
    Eur Urol. 2018 Nov;74(5):679-680. doi: 10.1016/j.eururo.2018.07.019.
    note
    Source null
    related pmid
    30104083
    relationship
    Comment in
  6. citation
    Cancer Biol Ther. 2019;20(1):6-7. doi: 10.1080/15384047.2018.1507260.
    note
    Source null
    related pmid
    30332546
    relationship
    Comment in
  7. citation
    Aktuelle Urol. 2019 Apr;50(2):136. doi: 10.1055/a-0603-7847.
    note
    Source null
    related pmid
    30897630
    relationship
    Comment in
  8. citation
    N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242369
    relationship
    Comment in
  9. citation
    N Engl J Med. 2019 Jun 27;380(26):2582. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242371
    relationship
    Comment in

Authors and identifiers

  1. name
    Motzer RJ
    type
    Author
  2. name
    Tannir NM
    type
    Author
  3. name
    McDermott DF
    type
    Author
  4. name
    Arén Frontera O
    type
    Author
  5. name
    Melichar B
    type
    Author
  6. name
    Choueiri TK
    type
    Author
  7. name
    Plimack ER
    type
    Author
  8. name
    Barthélémy P
    type
    Author
  9. name
    Porta C
    type
    Author
  10. name
    George S
    type
    Author
  11. name
    Powles T
    type
    Author
  12. name
    Donskov F
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Motzer RJ
    type
    Author
  2. name
    Tannir NM
    type
    Author
  3. name
    McDermott DF
    type
    Author
  4. name
    Arén Frontera O
    type
    Author
  5. name
    Melichar B
    type
    Author
  6. name
    Choueiri TK
    type
    Author
  7. name
    Plimack ER
    type
    Author
  8. name
    Barthélémy P
    type
    Author
  9. name
    Porta C
    type
    Author
  10. name
    George S
    type
    Author
  11. name
    Powles T
    type
    Author
  12. name
    Donskov F
    type
    Author
bibliography ids
  1. nci-bib-3879fa72ff883790d32810cd
book metadata
content sha256
bf7509d238c2677e644863918ec72bd1c87924299a9496a90151030fe6fb0c6a
document type
citation
dois
  1. 10.1056/NEJMoa1712126
electronic publication date
display
2018 Mar 21
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29562145
immutable id
pubmed:29562145@bf7509d238c2677e644863918ec72bd1c87924299a9496a90151030fe6fb0c6a
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
14
name
The New England journal of medicine
nlm unique id
0255562
pages
1277-1290
volume
378
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2018 Apr 5;378(14):1344-1345. doi: 10.1056/NEJMe1801682.
    note
    Source null
    related pmid
    29562143
    relationship
    Comment in
  2. citation
    Nat Rev Urol. 2018 May;15(5):261. doi: 10.1038/nrurol.2018.47.
    note
    Source null
    related pmid
    29632348
    relationship
    Comment in
  3. citation
    Nat Rev Clin Oncol. 2018 Jun;15(6):343. doi: 10.1038/s41571-018-0020-4.
    note
    Source null
    related pmid
    29666439
    relationship
    Comment in
  4. citation
    N Engl J Med. 2018 Jul 05;379(1):91-2. doi: 10.1056/NEJMc1805988.
    note
    Source null
    related pmid
    29975027
    relationship
    Comment in
  5. citation
    Eur Urol. 2018 Nov;74(5):679-680. doi: 10.1016/j.eururo.2018.07.019.
    note
    Source null
    related pmid
    30104083
    relationship
    Comment in
  6. citation
    Cancer Biol Ther. 2019;20(1):6-7. doi: 10.1080/15384047.2018.1507260.
    note
    Source null
    related pmid
    30332546
    relationship
    Comment in
  7. citation
    Aktuelle Urol. 2019 Apr;50(2):136. doi: 10.1055/a-0603-7847.
    note
    Source null
    related pmid
    30897630
    relationship
    Comment in
  8. citation
    N Engl J Med. 2019 Jun 27;380(26):2581. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242369
    relationship
    Comment in
  9. citation
    N Engl J Med. 2019 Jun 27;380(26):2582. doi: 10.1056/NEJMc1905518.
    note
    Source null
    related pmid
    31242371
    relationship
    Comment in
outcomes validated
false
pmid
29562145
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
d957f60b3fef2412295860ed2abdd63a2a2e7bda6c26c3256e6656d3506134fd
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Apr 5
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29562145/
title
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

Preserved source evidence · Not medical advice